Cresset Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.91M Buy
12,606
+11,156
+769% +$4.72M 0.02% 422
2026
Q1
$686K Buy
1,450
+23
+2% +$11.6K ﹤0.01% 927
2025
Q4
$666K Buy
1,427
+83
+6% +$38.5K ﹤0.01% 953
2025
Q3
$573K Buy
1,344
+107
+9% +$41.5K ﹤0.01% 965
2025
Q2
$474K Sell
1,237
-240
-16% -$86.5K ﹤0.01% 954
2025
Q1
$510K Sell
1,477
-71
-5% -$22.8K ﹤0.01% 1062
2024
Q4
$465K Sell
1,548
-12,778
-89% -$4.47M ﹤0.01% 1122
2024
Q3
$5.82M Buy
14,326
+2,465
+21% +$902K 0.02% 421
2024
Q2
$3.81M Buy
11,861
+2,787
+31% +$906K 0.02% 491
2024
Q1
$3.03M Buy
9,074
+744
+9% +$227K 0.01% 483
2023
Q4
$2.25M Sell
8,330
-3,042
-27% -$752K 0.01% 540
2023
Q3
$2.8M Buy
11,372
+149
+1% +$40.8K 0.01% 449
2023
Q2
$3.41M Buy
11,223
+10,206
+1,004% +$2.84M ﹤0.01% 504
2023
Q1
$268K Sell
1,017
-3
-0.3% -$762 0.01% 667
2022
Q4
$236K Sell
1,020
-181
-15% -$40.5K ﹤0.01% 606
2022
Q3
$222K Hold
1,201
﹤0.01% 765
2022
Q2
$200K Sell
1,201
-1,965
-62% -$422K ﹤0.01% 840
2022
Q1
$794K Sell
3,166
-202
-6% -$50.7K 0.01% 464
2021
Q4
$865K Sell
3,368
-1,419
-30% -$347K 0.01% 503
2021
Q3
$1.16M Buy
4,787
+988
+26% +$242K 0.02% 346
2021
Q2
$785K Buy
3,799
+284
+8% +$57.9K 0.01% 420
2021
Q1
$662K Buy
3,515
+909
+35% +$160K 0.01% 396
2020
Q4
$429K Sell
2,606
-70
-3% -$10.2K 0.01% 438
2020
Q3
$334K Sell
2,676
-182
-6% -$22.5K 0.01% 479
2020
Q2
$282K Sell
2,858
-39
-1% -$4.05K 0.01% 486
2020
Q1
$260K Buy
2,897
+96
+3% +$12.4K 0.01% 439
2019
Q4
$414K Buy
2,801
+689
+33% +$92.5K 0.01% 339
2019
Q3
$254K Buy
2,112
+147
+7% +$19K 0.01% 429
2019
Q2
$266K Sell
1,965
-1,115
-36% -$141K 0.01% 362
2019
Q1
$402K Buy
3,080
+2,861
+1,306% +$384K 0.02% 217
2018
Q4
$27K Buy
+219
New +$29.4K ﹤0.01% 651

Other funds holding HCA

Cresset Asset Management's HCA Position: Q2 2026 in Review

Cresset Asset Management increased its HCA Healthcare (HCA) stake by 769% in Q2 2026, buying an estimated $4.72M and bringing the position to 12,606 shares worth $4.91M. The position accounts for 0.02% of the portfolio, ranked #422.

Cresset Asset Management first reported a position in HCA in Q4 2018 and has held it in 31 quarters since. The position peaked at $5.82M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Cresset Asset Management held 12,606 shares of HCA Healthcare worth $4.91M as of Q2 2026.
  • Cresset Asset Management bought 11,156 HCA Healthcare shares in Q2 2026, an estimated $4.72M.
  • HCA Healthcare made up 0.02% of Cresset Asset Management's portfolio in Q2 2026, its #422 holding.
  • Cresset Asset Management first reported a position in HCA Healthcare in Q4 2018 and has held it in 31 quarters since.
  • Cresset Asset Management's HCA Healthcare position peaked at $5.82M in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.